Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005570
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
2000-04-22
Brief Title:
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts Endogenous Thrombopoietin Levels Endogenous Anti-Thrombopoietin Antibodies and Selected Autoimmune Markers
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts Endogenous Thrombopoietin Levels Endogenous Anti-Thrombopoietin Antibodies and Selected Autoimmune Markers
Status:
COMPLETED
Status Verified Date:
2000-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study involves the collection of blood samples from patients with immune thrombocytopenic purpura ITP to evaluate the relationship between platelet counts blood levels of a hormone called thrombopoietin that controls platelet production by the bone marrow and blood levels of antibodies against thrombopoietin that could interfere with the action of this hormone Blood samples will also be stored if separately agreed to by the patient for analysis of genes that might affect platelet production At a single outpatient clinic visit patients will have a medical history taken and blood samples drawn for testing Results from this study may help further understand the control of platelet production in patients with ITP and suggest new therapeutic approaches
Detailed Description:
This study involves the collection of blood samples from patients with immune thrombocytopenic purpura ITP to evaluate the relationship between platelet counts blood levels of a hormone called thrombopoietin that controls platelet production by the bone marrow and blood levels of antibodies against thrombopoietin that could interfere with the action of this hormone Blood samples will also be stored if separately agreed to by the patient for analysis of genes that might affect platelet production At a single outpatient clinic visit patients will have a medical history taken and blood samples drawn for testing Results from this study may help further understand the control of platelet production in patients with ITP and suggest new therapeutic approaches
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 00-H-0120 | None | None | None |